Therapy News and Research

RSS

Diet could avert toxic effects of quinine in patients with malaria

Scientists at The University of Nottingham say adverse side-effects caused by the anti-parasitic drug quinine in the treatment of malaria could be controlled by what we eat.

12 Sep 2012

APS conference to explore potential mechanisms behind health benefits of exercise

The effects of physical inactivity are, literally, hazardous to your health. Although the detrimental effects of being inactive are generally thought to be associated with childhood obesity and Type 2 diabetes, they have a significant impact on other illnesses. Physical inactivity contributed at least 25 percent to the prevalence of hip fractures, osteoporosis, coronary heart disease, and colon cancer according to recent data released by the U.S. Department of Health and Human Services.

12 Sep 2012

New model reveals how immune system functions under conditions of neutropenia

Cancer chemotherapy can be a life-saver, but it is fraught with severe side effects, among them an increased risk of infection. Until now, the major criterion for assessing this risk has been the blood cell count: if the number of white blood cells falls below a critical threshold, the risk of infection is thought to be high.

12 Sep 2012

iPad app revolutionising therapy for autistic children

Australian researchers have harnessed tablet technology to develop an iPad app that is set to revolutionise the way parents around the world provide in-home therapy for their autistic children.

12 Sep 2012

KaloBios commences KB003 Phase 2 trial in severe asthma

KaloBios Pharmaceuticals, Inc. today announced that dosing has begun in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of KB003, the company's anti-GM-CSF Humaneered monoclonal antibody, in subjects with severe asthma uncontrolled by corticosteroids.

12 Sep 2012

Book provides holistic view of post-traumatic stress disorder

Close to 5.2 million adults experience post-traumatic stress disorder (PTSD) every year. And it can affect anyone — from war veterans and abuse victims to persons directly or indirectly traumatized by violence, natural disaster or other catastrophes.

12 Sep 2012

Berkeley lab researchers link possible new oncogene with resistance to cancer drugs

A gene that may possibly belong to an entire new family of oncogenes has been linked by researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) to the resistance of breast cancer to a well-regarded and widely used cancer therapy.

12 Sep 2012

ApoB no better than current lipid markers in CVD risk prediction

Assessment of apolipoprotein B levels does not seem to improve cardiovascular disease risk prediction over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol, report researchers.

11 Sep 2012

Aortic stiffness linked to high blood pressure

Higher aortic stiffness is linked with an increased risk for hypertension, a study in JAMA suggests.

11 Sep 2012

Instrument-assisted spinal manipulation shows hypoalgesic effects

Instrument-assisted spinal manipulative therapy targeted to the low-back region has an immediate and widespread hypoalgesic effect, say researchers.

11 Sep 2012

Nonsurgical treatment achieves periodontitis improvements regardless of smoking

Both smokers and nonsmokers with the chronic inflammatory disease periodontitis have significantly improved clinical markers, including probing depth and plaque index, after nonsurgical periodontal therapy, show study results.

11 Sep 2012

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]flutemetamol, which showed a strong concordance between [18F]flutemetamol images and Alzheimer's disease-associated beta amyloid brain pathology.

11 Sep 2012

BRI scientists receive two major grant awards for research into autoimmunity prevention

Benaroya Research Institute at Virginia Mason (BRI) recently received two major grant awards to explore how to regulate the immune system, as part of a nationwide collaborative program to prevent autoimmune diseases.

11 Sep 2012

Two National University of Singapore scientists win Lasker Awards for medical research

Two scientists from the National University of Singapore (NUS) - Professor Michael Sheetz, Director of the Mechanobiology Institute of Singapore; and Professor Roy Calne, Visiting Professor with the NUS Yong Loo Lin School of Medicine's Department of Surgery - have been conferred the prestigious Lasker Awards for making great advances in medical research.

11 Sep 2012

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of two major grants for the development of monoclonal antibody therapeutics against nosocomial infections.

11 Sep 2012

KRAS gene mutation recruits second player to trigger pancreatic cancer

More than a cancer-causing gene is needed to trigger pancreatic cancer, a study led by Mayo Clinic has found. A second factor creates a "perfect storm" that allows tumors to form, the researchers say. The study, published in the Sept. 10 issue of Cancer Cell, overturns the current belief that a mutation in the KRAS oncogene is enough to initiate pancreatic cancer and unrestrained cell growth.

11 Sep 2012

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

11 Sep 2012

Cardiac stem cells from newborns show stronger regenerative ability

Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat serious heart problems in children, have conducted the first direct comparison of the regenerative abilities of neonatal and adult-derived human cardiac stem cells.

11 Sep 2012

Cell Therapeutics launches Pixuvri in the European Union

Cell Therapeutics, Inc., a company focused on translating science into novel cancer therapies, today announced the initiation of the commercial launch of Pixuvri in the European Union with entry into Sweden, Denmark and Finland in September, to be followed by Austria and Norway in early October 2012 and Germany, United Kingdom and the Netherlands in November 2012.

11 Sep 2012

Eaton plans to begin development of transdermal patch delivery system for Tropine 3

Eaton Scientific Systems, Ltd. a wholly-owned subsidiary of Pristine Solutions, Inc. is pleased to announce that the Company plans to begin development of a transdermal patch delivery system for Tropine 3, a patent pending novel indication of homatropine for non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women.

11 Sep 2012

Therapy News and Research

Diet could avert toxic effects of quinine in patients with malaria

APS conference to explore potential mechanisms behind health benefits of exercise

New model reveals how immune system functions under conditions of neutropenia

iPad app revolutionising therapy for autistic children

KaloBios commences KB003 Phase 2 trial in severe asthma

Book provides holistic view of post-traumatic stress disorder

Berkeley lab researchers link possible new oncogene with resistance to cancer drugs

ApoB no better than current lipid markers in CVD risk prediction

Aortic stiffness linked to high blood pressure

Instrument-assisted spinal manipulation shows hypoalgesic effects

Nonsurgical treatment achieves periodontitis improvements regardless of smoking

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

BRI scientists receive two major grant awards for research into autoimmunity prevention

Two National University of Singapore scientists win Lasker Awards for medical research

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

KRAS gene mutation recruits second player to trigger pancreatic cancer

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

Cardiac stem cells from newborns show stronger regenerative ability

Cell Therapeutics launches Pixuvri in the European Union

Eaton plans to begin development of transdermal patch delivery system for Tropine 3

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News